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DOCTORING PRESCRIPTIONS: FEDERAL BARRIERS
TO COMBATING PRESCRIPTION DRUG FRAUD
AGAINST ON-LINE PHARMACIES IN WASHINGTON
Eric M. Peterson
Abstract- Prescription drug abuse represents a significant portion of drg abuse in the
United States. Drug-seeking individuals alter, steal, or forge prescriptions to sustain their own
dependence on prescription medications or to divert the drugs to sell to others at inflated rates.
On-line pharmacies are a relatively new source for prescription medications and a potential
target for prescription drug fraud. The federal government recently enacted the Electronic
Signatures in Global and National Commerce Act (E-SIGN), which governs electronic
signatures and preempts inconsistent provisions of state laws, such as the Washington
Electronic Authentication Act (WEAA). WEAA is a legal framework that could be effectively
amended to eliminate nearly all prescription drug fraud perpetrated against on-line
pharmacies. However, E-SIGN preempts a crucial WEAA provision and prohibits enacting a
key recommended amendment to WEAA, both of which are necessary to combat this
problem. Options permissible after E-SIGN, such as voluntary self-regulation by the on-line
pharmacy industry and amendment of WEAA, will not comprehensively and effectively
prevent this type of fraud. Therefore, E-SIGN fundamentally alters Washington's ability to
protect the public's health, safety, and welfare from prescription fraud perpetrated against on-
line pharmacies.
Mark' is a thirty-three-year-old professional who is addicted to the
prescription anti-anxiety medication Xanax.2 At age twenty-nine, Mark
began using Xanax under the care of his physician to treat anxiety attacks
associated with the airline travel required by a new job. Xanax
successfully treated Mark's symptoms and he revisited his physician,
who authorized one additional refill and recommended a counselor to
help Mark learn to manage his fear of flying. However, Mark failed to
schedule an appointment with the counselor and suffered through two
extremely frightening flights after he ran out of Xanax. He returned to
his physician's office and promised to schedule an appointment with the
counselor. The physician gave Mark an additional prescription for Xanax
with two refills to last until he could schedule the appointment,
admonishing him that there would be no further refills until Mark had
seen the counselor. By the end of the second refill, Mark was using
Xanax to cope with causes of stress other than just flying.
1. This scenario is a hypothetical created by the author.
2 Xanax is the brand name of the generic drug alprazolam, which is primarily used to treat
anxiety disorders and can cause psychological dependence. See Medical Economics Company,
Physicians Desk Reference (54th ed. 2000).
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When the medication from Mark's final refill was nearly gone he
began to imagine ways to obtain Xanax without a prescription. Mark
used his computer to create a fake prescription form. He filled out a
prescription for Xanax, forged his physician's signature, and indicated
three refills. Late one evening, Mark presented the forged prescription to
a pharmacist. Mark made nervous small talk, which might have created
suspicion. Nonetheless, the pharmacist filled the prescription without
verifying it with Mark's physician because the pharmacist knew the
clinic was closed.
Nearly three months later, as Mark was nearing the end of his final
refill from the fraudulent prescription, he decided to find a more
anonymous method for his deception. Mark filled out another forged
prescription with two refills. He substituted his cellular telephone
number for the physician's clinic number and mailed the fraudulent
prescription to an on-line pharmacy.3 A few days later the on-line
pharmacy called his cellular number to verify the prescription. Mark
answered several simple questions based on his knowledge of the
medication and three days later the medication arrived at his home in the
mail. When he needed a refill, he simply accessed the on-line
pharmacy's home page using his computer and ordered the refill. Mark
used this technique for three years, varying the on-line pharmacy he used
to avoid attracting attention to both his fraud and addiction.
Mark's situation is surprisingly common in the United States, where
prescription drug abuse makes up a large portion of the drug abuse
problem.4 Two categories of people engage in prescription drug fraud in
the United States: prescription drug abusers who perpetrate fraud to
maintain an addiction and individuals who obtain prescription
medications to divert them for sale to an illegal street market.'
Prescription fraud can be relatively simple to accomplish and is not
always detectable by pharmacists, particularly those working for on-line
pharmacies. Altering, forging, and photocopying prescriptions are
common methods of perpetrating prescription fraud.6  Although
pharmacists use a variety of methods to detect prescription drug fraud,7
3. Xanax is available from on-line pharmacies. See drugstore.com (visited Sept. 26, 2000)
<http://drugstore.com/help/questions.asp?label=drugprices>
4. See infra notes 21-28 and accompanying text.
5. See generally Bonnie Wilford, Abuse of Prescription Drugs, 152 W.J. Med. 609 (1990).
6. See Karen Blumenschein, Prescription Drug Diversion: Fraudulent Tactics Utilized in the
Community Pharmacy, 61 Am. J. Pharmaceutical Educ. 184, 185-86 (1997).
7. See James Keown et al., Prescription Fraud, Am. Pharmacy, Dec. 198 1, at 19.
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these methods are not always successful because prescription fraud can
be quite sophisticated.8
On-line pharmacies are uniquely vulnerable to prescription fraud.
Unlike community pharmacists, an on-line pharmacist is unable to
evaluate the behavior of patients presenting prescriptions,9 is unlikely to
be familiar with the signatures of distant physicians, ° and may have
difficulty verifying prescriptions with piescribing physicians because
drug-seeking individuals can provide false telephone numbers and verify
prescriptions themselves." Thus, on-line pharmacies exacerbate the
problems faced in combating prescription fraud.
The Electronic Signatures in Global and National Commerce Act (E-
SIGN) is not an effective tool to prevent prescription drug fraud against
on-line pharmacies. E-SIGN ensures that digital signatures in nearly all
types of communications are not denied legal recognition solely because
of their electronic form.'3 However, E-SIGN lacks the necessary
provisions governing electronic signatures that would create a
comprehensive and effective law to prevent prescription drug fraud
against on-line pharmacies nationwide. 4
Unlike E-SIGN, the Washington Electronic Authentication Act
(WEAA)5 is a state law that, if amended, could effectively prevent
prescription drug fraud against on-line pharmacies. WEAA grants
electronic signatures the equivalent legal status of handwritten
signatures. 6 WEAA also requires the use of electronic signature
technology that offers users the ability to verify both if a message has
been altered and the identity of the sender. 7
However, E-SIGN preempts statutes and regulations that are
inconsistent with E-SIGN.' E-SIGN prohibits both a crucial existing
WEAA provision and a necessary amendment that would nearly
eliminate prescription drug fraud against on-line pharmacies in
8. See Blumenschein, supra note 6, at 186.
9. SeeA Tricky Prescription, Newsday, Mar. 8, 1999, at C7.
10. See id.
11. See Blumenschein, supra note 6, at 186.
12. Pub. L. No. 106-229, 114 Stat. 464 (2000).
13. See Pub. L. No. 106-229, § 101(a), 114 Stat. 464,464.
14. See infra note 215.
15. Wash. Rev. Code § 19.34 (1998).
16. See Wash. Rev. Code § 19.34.0 10.
17. See Wash. Rev. Code § 19.34.020(11).
18. Pub. L. No. 106-229, § 102(a), 114 Stat. 464,467.
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Washington and effectively protect the public's health, safety, and
welfare. 9 Therefore, not only is E-SIGN itself an ineffective tool for
nearly eliminating prescription fraud against on-line pharmacies, it
precludes state laws and regulations that otherwise would achieve this
goal through an effective and comprehensive regulatory framework.
Part I of this Comment examines the problem of prescription drug
abuse and fraud against community pharmacies and how these problems
are exacerbated in the context of on-line pharmacies. Part II explains the
technology available for transmitting private electronic communications
between individuals to guarantee against alteration of data. It also
describes E-SIGN and WEAA, which both ensure the legal validity of
electronic communications using digital signatures. Part III discusses the
effects of E-SIGN on both WEAA and efforts to combat prescription
fraud against on-line pharmacies. It demonstrates how E-SIGN threatens
Washington's ability to protect the public's health, safety, and welfare
from this problem. Part IV examines potential options for combating
prescription drug fraud against on-line pharmacies after E-SIGN. It
recommends that Washington funds not be used to pay for prescriptions
dispensed by on-line pharmacies that do not require the electronic
transmission of prescriptions using asymmetric cryptography. It also
examines the arguments for self-regulation by the on-line pharmacy
industry and reviews the limitations of this approach.
I. THE PERPETRATION OF PRESCRIPTION DRUG FRAUD
AGAINST COMMUNITY AND ON-LINE PHARMACIES
Prescription drug abuse constitutes a significant portion of the drug-
abuse problem in the United States. Several factors affect the prevalence
of prescription drug abuse, including the availability of prescription
medications, physician prescribing habits," and patient expectations.
Despite attempts by pharmacists to detect prescription fraud, patients can
subvert the process for filling a legitimate prescription and illegally
obtain prescription medications. The problem of prescription drug fraud
is even more acute in the growing market of on-line pharmacies.
19. See infra notes 224-25 and accompanying text.
20. This Comment uses the term "physician" to mean any medical provider with the licensed
authority to write prescriptions. Depending on the jurisdiction, this may include physicians, dentists,
nurse practitioners, and physician assistants. See, e.g., Wash. Rev. Code § 18.32.091 (1998)
(licensing dentists); Wash. Rev. Code § 18.71.021 (1998) (licensing physicians); Wash. Rev. Code
§ 18.71A.020 (1998) (licensing physician assistants); Wash. Rev. Code § 18.79.030 (1998)
(licensing advanced nurse practitioners).
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A. The Problem ofPrescription Drug Abuse in the United States
Prescription drug abuse is a major social problem in the United
States.2' Prescription drug abuse is the inappropriate use of medications,
which results in an individual's loss of control over use of a drug and
continued use despite negative consequences.' One-third of the total
drug abuse problem in the United States has been attributed to
prescription drugs.' The problem extends to all socioeconomic and
geographic segments of society, from suburban housewives to street
addicts.24 Approximately three percent of the U.S. population
deliberately misuses or abuses prescription drugs each year.25 The
National Household Survey of Drug Abuse estimates that 15.7% of the
U.S. population over twelve years of age has used prescription
psychotherapeutic drugs26 for non-medical reasons at some point in
time. Approximately two-thirds of all drug-related injuries and deaths
involve prescription drugs.2"
There are two general categories of prescription drug abusers.29 The
first category includes individuals with previously established drug
dependencies on substances other than those legitimately prescribed by a
physician." For these individuals, a prescribed medication is a "very
attractive street drug"' because it offers a degree of "label confidence
and safety."32  The second category includes iatrogenic drug
21. See Douglas J. Behr, Prescription Drug Control Under the Federal Controlled Substances
Act: A Web ofAdministrative, Civil, and Criminal Law Controls, 45 Wash. U. J. Urb. & Contemp. L.
41,41 (1994).
22. See James Finch, Prescription Drug Abuse, Primary Care, Mar. 1993, at 233.
23. See Blumenschein, supra note 6, at 184.
24. See Behr, supra note 21, at 43.
25. See Blumenschein, supra note 6, at 184.
26. Psychotherapeutic drugs are prescribed to relieve mental disorders. See Mosby's Medical,
Nursing, and Allied Health Dictionary 1349 (5th ed. 1998) [hereinafter Mosby's Dictionary].
27. See Mark Britton et al., Multidisciplinary Committee on the Abuse of Prescription
Medications, 51 Am. J. Hosp. Pharmacy 85, 85 (1994).
28. See Behr, supra note 21, at 44.
29. See Wilford, supra note 5, at 609.
30. See Finch, supra note 22, at 237.
31. Behr, supra note 21, at 42.
32 Kevin Beaty, Countering Prescription Fraud, Police Chief, Mar. 1996, at 33. Prescription
drugs offer a sense of safety to drug abusers because they can achieve the desired
psychopharmacologic effect while reducing the risks associated with consuming unknown
substances. See id.
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dependence.33 An iatrogenic result is an unintended harm caused by
medical treatment designed to benefit a patient. 34  For example, a
medication prescribed for pain control also may result in addiction, an
iatrogenic result. latrogenic drug dependence develops from poorly
managed prescription practices by physicians, the use of multiple
physicians, or self-medication that does not comply with a physician's
directions. 3
5
Physician prescribing habits and patient expectations both contribute
to prescription drug abuse.36 Many patients in the United States respond
to a societal "mania" for the use of medications by expecting a "quick
pharmacologic fix for all forms of distress., 37 Therefore, common patient
complaints such as anxiety, chronic pain, stress, and insomnia often
result in prescription drug treatment. 38 These prescribing patterns pose
the potential for iatrogenic drug dependence.39
The quantity of prescription medications also affects the prevalence of
prescription drug abuse.4" Legitimately manufactured prescription drugs
comprise thirteen of the top twenty controlled substances4& ' most
frequently resulting in emergency room visits in the United States.42
More than 231 million prescriptions are written for controlled substances
per year; this figure does not include controlled substances dispensed in
hospitals.43 The most frequently prescribed medications are among the
33. See Wilford, supra note 5, at 609.
34. See Dictionary of Pharmacy 153 (1986).
35. See Wilford, supra note 5, at 609.
36. See Finch, supra note 22, at 231-32.
37. Id. at 232.
38. See id. at231.
39. See Wilford, supra note 5, at 609-12. Physicians may be liable for malpractice if they cause
an addiction by providing indiscriminate prescriptions. See Michael J. Farrell, Medication
Malpractice: Claims, Culprits and Defenses, 16 Am. J. Trial Advoc. 65, 75-76 (1992). Physicians
can assert that they "reasonably monitored" a patient's drug usage or that the "patient misrepresented
facts to induce additional undetected prescriptions." Id. at 76. However, a patient is not
contributorily negligent for the solicitation and use of addictive drugs if a patient does not know the
doctor is negligent. See Ballenger v. Crowell, 247 S.E.2d 287, 291 (N.C. Ct. App. 1978).
40. See Harold Davis, Indices of Drug Misuse for Prescription Dngs, 26 Int'l J. Addictions 777,
781 (1991).
41. Controlled substances are any drugs defined in the five categories of the Uniform Controlled
Substances Act of 1970. See Mosby's Dictionary, supra note 26, at 396.
42. See Edgar Adams, Prevalence of Prescription Dng Abuse: Data from the National Institute
of Drug Abuse, N.Y. St. J. Medicine, Nov. 1991, at 11; see also Kurt M. Dubowski, Dng Use
Testing: Scientific Perspectives, 11 Nova L. Rev. 415, 425 (1987).
43. See Beary, supra note 32, at 33.
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most frequently misused or abused, including drugs such as Xanax and
Valium.4
Prescription drugs are tightly regulated because of their potential for
abuse, causing some prescription drug abusers to turn to illicit means to
maintain their addictions. The federal government regulates prescription
drags under the Uniform Controlled Substances Act,45 which categorizes
all drugs into five schedules according to their potential for abuse46 as
determined by the Drug Enforcement Administration (DEA).47 Although
theft and burglary are sometimes used, most prescription drug abusers
acquire drugs via prescription fraud.41 The perpetrators of prescription
fraud may be individual addicts, such as Mark, or third parties who
acquire prescription drugs through fraud and then divert them for illegal
sale to others.49 A significant component of the drug problem in the
United States involves legally produced drugs diverted to illicit channels
of distribution." The street sale of diverted prescription medications
generates large profits,5' with brand-name products tending to have a
higher street value because of name and sight recognition.52
B. The Process ofFilling a Legitimate Prescription at a Community
Pharmacy
Strict limitations govern who may prescribe medications and for what
purposes. To issue a prescription,53 physicians must be authorized by
44. See Finch, supra note 22, at 23 1.
45. See Uniform Controlled Substances Act of 1970, 21 U.S.C. §§ 801-904 (1994) (governing
manufacturing, distribution, and dispensing of controlled substances).
46. See 21 U.S.C. § 812.
47. See Pharmacy Law Digest CS-3 (Joseph Fink et al. eds., 34th Revision July 1998).
48. See Wilford, supra note 5, at 609-12.
49. See id.
50. See Behr, supra note 21, at 44.
51. See id. at 42.
52. For example, a one-milligram tablet of Xanax costs $1A0 if purchased at a pharmacy,
compared to a street value of $5 to $10. See Blumenschein, supra note 6, at 185 (providing street
value price); interview with pharmacist at Bartell's Drug Store in Seattle, Wash. (Jan. 10, 2000)
(providing community-pharmacy prices).
53. Prescriptions are usually written on printed forms that contain the name, address, telephone
number, and other information about the physician's practice. A prescription should include patient
information such as name, address, and date of birth; the date of the prescription; an "R," symbol
(contraction of the Latin verb recipe meaning "you take"); the medication prescribed; the dispensing
directions to the pharmacist directions for use by the patient; any refills or other special instructions;
1337
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state authorities to prescribe controlled substances54 and be registered
with the DEA 5 Physicians receive individual DEA numbers authorizing
them to prescribe controlled substances.56 A prescription for controlled
substances must be issued for a "legitimate medical purpose by a
practitioner acting in the usual course of his professional practice.
5 7
Prescriptions used to maintain drug-dependent individuals are not valid. 8
The process of obtaining prescription medication with a legitimate
paper prescription at a community pharmacy 9 is relatively simple. A
patient presents a legitimate paper prescription to a pharmacist.' The
pharmacist or pharmacy technician usually obtains a patient's insurance
or payment information, collects any required payment, and inquires if
the individual is taking any other medications.6 The pharmacist then
evaluates whether any potential drug interactions exist and counsels a
patient regarding the appropriate use of the prescribed medication.6"
Finally, the medication is dispensed.63
Community pharmacies also accept prescriptions from physicians via
telephone and facsimile and transferred from other pharmacies.'
Physicians can telephone a patient's chosen pharmacy and prescribe
most medications over the phone.65 Pharmacists may ask physicians to
provide their DEA number authorizing them to prescribe medications or
their state license number, and possibly engage physicians in a brief
conversation using medical jargon regarding the patient's diagnosis and
the prescriber's signature; and the prescriber's DEA number. See Remington "s Pharmaceutical
Sciences 1828 (Alfonso R. Gennaro et al. eds., 18th ed. 1990) [hereinafter Remington 's].
54. See Wash. Rev. Code § 18.71.011(2) (1998) (defining practice of medicine to include
prescribing controlled substances); Wash. Rev. Code § 18.71.021 (1998) (requiring valid license to
practice medicine).
55. See Remington's, supra note 53, at 1925.
56. See id.
57. Id.
58. See id.
59. As used in this Comment, the term "community pharmacy" refers exclusively to brick-and-
mortar pharmacies and excludes both mail-order and on-line pharmacies.
60. See Remington's, supra note 53, at 1830.
61. See id. at 1828-35.
62. See id. at 1834-37.
63. See id. at 1828-35.
64. The Washington Pharmacy Board is authorized to adopt rules governing the electronic
communication of prescription information. See Wash. Rev. Code § 69.50.312 (1998). Thus, a
prescription for a controlled substance may be electronically communicated to a pharmacy if the
process complies with Washington statutes. See Wash. Rev. Code § 69.50.312.
65. See Remington's, supra note 53, at 1926.
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condition.' Pharmacists may also telephone clinics to verify facsimile
prescriptions." In addition, pharmacies accept prescriptions transferred
from one pharmacy to another at the request of patients."
C. General Methods ofPrescription Drug Fraud
Drug-seeking individuals69 obtain prescription drugs illegally through
alteration, theft, or forgery.70 Burglary and .robbery are less frequent
methods of obtaining prescription drugs illegally, primarily because of
the more severe penalties for these crimes and increased security
measures in pharmacies.7 As a result of increased security measures,
prescription fraud has increased both in frequency and sophistication.72
According to the DEA, prescription fraud accounts for nearly half of the
legally manufactured controlled substances that are diverted to illegal
use.
73
Altering a legitimate prescription is the easiest method of prescription
fraud.74 Changing the quantity, strength, or number of refills on a
legitimate prescription is fairly simple, particularly when the quantity or
strength is not spelled out in words, but rather written in Arabic
numerals.75 In addition, a second drug may be added to an otherwise
legitimate prescription.76
Stealing blank prescription pads and prescription forgery are ad-
ditional methods of perpetrating prescription fraud. Blank prescription
pads may be illegally used in a manner similar to forging a blank check.77
However, fewer security precautions exist to scrutinize paper
prescriptions as compared to protections used to verify the accuracy and
66. See Blumenschein, supra note 6, at 187.
67. See Keown, supra note 7, at 19.
68. See Wash. Admin. Code § 360-16-094 (1999).
69. This Comment uses the term "drug-seeking individual" to refer those who perpetrate
prescription fraud to maintain addictions or divert drugs for illegal sale or both.
70. See Wilford, supra note 5, at 609.
71. See Blumenschein, supra note 6, at 185.
72. See idJ
73. See Keown, supra note 7, at 18.
74. See Blumenschein, supra note 6, at 186.
75. See id. For example, the Arabic number 10 can easily be changed to 40 or 100. Likewise, the
number 30 can be altered to 80 with little chance of detection.
76. See Blumenschein, supra note 6, at 186.
77. See id. at 186.
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authenticity of checks.78 In addition, prescription drug pads can be
ordered from a print shop without any special credentials or created with
a home computer.79 Having created or obtained a blank prescription pad,
an individual with a basic knowledge of prescription formats can forge
prescriptions with relative ease and sophistication by entering all the
necessary information and forging a physician's signature.8"
D. Methods Available for Pharmacists to Detect Prescription Fraud
Pharmacists have a legal duty of vigilance when dispensing
prescriptions for controlled substances. Federal law forbids pharmacists
from dispensing prescription medications if the pharmacist harbors any
doubts concerning the legitimacy of the prescription.82 Pharmacists may
refuse to fill or refill a prescription if they suspect that a prescription is
forged.83 Nonetheless, because of the relative ease of perpetrating
prescription fraud and the difficulty of detecting it,' pharmacists
unknowingly fill fraudulent prescriptions despite following established
precautions.
The DEA recommends a variety of methods to detect fraudulent
prescriptions for community pharmacies.86 The pharmacist should know
the physician, the physician's signature, and the physician's DEA
78. See id.
79. See id.
80. The information necessary to complete a prescription is widely available from a variety of
sources that show the format of a prescription as well as the common terms and abbreviations used
by physicians when writing a prescription. See, e.g., Basic and Clinical Pharmacology 970-72
(Bertram Katzung ed., 6th ed. 1995).
81. See Uniform Controlled Substances Act of 1970, 21 U.S.C. §§ 812, 829 (1994).
82. Under the statute, a prescription for controlled substances can only be issued for a legitimate
medical purpose. See 21 U.S.C. §§ 812, 829. It is the responsibility of the physician and the
pharmacist to ensure the proper prescribing and dispensing of controlled substances. See 21 U.S.C.
§§ 812, 829; see also United States v. Kershman, 555 F.2d 198, 200 (8th Cir. 1977) (affirming
conviction of pharmacist for knowing and intentional distribution of controlled substances when
pharmacist deliberately ignored good reasons to believe prescriptions were not for legitimate
medical purpose). A person knowingly filling a prescription that is not issued for legitimate medical
treatment is subject to penalties. See 21 U.S.C. §§ 812, 829. Washington enacted a similar statute.
See Wash. Rev. Code § 69.50 (1998).
83. See Pharmacy Law Digest, supra note 47, at CL-37.
84. See interview with pharmacist at Bartell's Drug Store in Seattle, Wash. (Jan. 10, 2000).
85. See id.
86. See Keown, supra note 7, at 16.
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number." In addition, the pharmacist should be familiar with the
patient." The DEA recommends using a patient profile form to
discourage fraudulent prescriptions by tracking patient demographics and
medication usage.89 Finally, the DEA recommends that pharmacists ask a
patient for a plausible explanation for any discrepancy in the prescription
and, if suspicious, telephone the physician for verification.90
When a prescription is presented at a community pharmacy,
pharmacists can directly observe a patient's behavior to detect
prescription fraud.9' Individuals committing fraud commonly remain
close to the pharmacy counter while the prescription is being filled,
engage in excessive conversation with the pharmacist, and become
irritated or angry at delays.92 Pharmacists practicing in community
pharmacies develop a sense for patients who attempt to fill fraudulent
prescriptions based on the totality of the circumstances presented.93 In
addition, pharmacists in community pharmacies use their familiarity with
local physicians and patients to evaluate prescriptions for fraud.94
Pharmacists also may ask for identification from a patient.95
Pharmacists also can closely examine the paper prescriptions
presented by patients by evaluating the consistency of the ink used, any
variations in writing styles, and other cues on the paper prescription,
such as photocopy residue.96 Pharmacists also use their therapeutic
knowledge to evaluate the amount or type of medication prescribed for a
patient's reported disease or condition.97 Other incongruities also may
indicate that the prescription is fraudulent, such as a dentist prescribing
anti-anxiety medications or a psychiatrist prescribing a narcotic pain
medication.98
87. See id.
88. See id.
89. See id.
90. See id.
91. See Tanika Simmons, Prescription Fraud Seen in Rising Doses, Fort Lauderdale Sun-
Sentinel, Sept. 17, 1998, at 4B.
92. See id.
93. See generally Blumenschein, supra note 6.
94. See id.
95. See Keown, supra note 7, at 19; see generally Blumenschein, supra note 6.
96. See generally Blumenschein, supra note 6.
97. See id.
98. See Simmons, supra note 91, at 4B.
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E. Consumer Use of On-line Pharmacies
The development of on-line commerce has expanded into the
pharmaceutical field.99 The pharmaceutical market is worth approx-
imately $90 billion annually in the United States."°° The first large and
exclusively on-line pharmacies began filling prescriptions as recently as
1999.0' Since then, a growing number of on-line pharmacies has
attempted to capture business from community pharmacies"0 ' by forming
partnerships with familiar names such as America Online, Yahoo.com,
Women.com,0 3 and the Mayo Clinic"° to develop exposure and
credibility among potential consumers. However, an estimated 400 sites
currently sell prescription medications on-line." 5 As on-line pharmacies
become more prevalent they are likely to take business away from
community pharmacies.0 6 Fearing a loss of customers and profits similar
to the experience of large bookstore retailers that waited too long to go
on-line," 7 many community pharmacies seek to provide same-day
delivery to patients by combining on-line and community-pharmacy
services.'08
The convenience and occasionally lower prices of on-line pharmacies
appeal to consumers. 9 On-line pharmacies are convenient for the
99. See Evelyn Nussenbaum, Prescription Plan, Pharmacies Poised for Web Boom, N.Y. Post,
Mar. 26, 1999, at 38.
100. See id.
101. See Jonathan Gaw, Pharmacies to Compete on the Internet Soon, L.A. Times, Feb. 20, 1999,
at IA; see also Janet Rae-Dupree, A Real Shot in the Arm for a Virtual Pharmacy, Bus. Wk., Mar. 8,
1999, at 40 (noting drugstore.com and PlanetRx.com).
102. See Net Pharmacies Preparing to Fill Prescriptions Online, Computer Service Likely to Take
Business away from Drugstores, Star Tribune, Minneapolis, Feb. 28, 1999, at 6D [hereinafter Net
Pharmacies].
103. See Robert McGarvey, Does drugstore.com Have the Right Prescription for a Crowded
Market?, Upside Mag., Aug. 1, 1999, at 46.
104. See Shari Roan, Cyberspace Prescriptions: How e-Pharmacies Work, Kan. City Star, Oct. 3,
1999, at F5.
105. See Steve Sternberg, Clinton Wants FDA to Control Drug Sales Online, USA Today, Dec.
29, 1999, at 6D.
106. See Net Pharmacies, supra note 102, at 6D.
107. See Mark Albright, Net Dosage, St. Petersburg Times, July 5, 1999, at 8.
108. See Connie Guglielmo, Drugstore Wars: Web Remedy, Interactive Wk. from ZDWire, Sept.
13, 1999, available in 1999 WL 14630009, at *1.
109. See Gaw, supra note 101, at IA.
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elderly,"' those living in rural areas,"' and those wanting personal
privacy or seeking to avoid the hassle of lines and waiting time at a
community pharmacy."' Sending patients e-mails reminding them to
refill prescriptions is another appeal of on-line pharmacies."' On-line
pharmacies have lower operating costs than community pharmacies and
generally pass these savings on in the form of lower prices."' Because
mail-order pharmacies deliver one out of every seven prescriptions in the
United States, many consumers are already familiar with obtaining
prescription drugs from sources other than community pharmacies and
are comfortable buying them sight-unseen."'
To purchase prescription medications on-line, a patient must register
with the on-line pharmacy and provide an e-mail account. 1 6 A patient
creates an individual account with the on-line pharmacy, using a
password for privacy protection." 7 Next, a patient submits insurance
information or a credit card number for payment." 8 Then, a patient must
complete a health profile, including patient demographic data, drug
allergies, medical conditions or illnesses, and current medications." 9
Next, a patient enters the name of the medication on the prescription'2"
and completes the checkout process.' Customers pay for their orders
110. See Drugstores on the Net: The Benefits and Risks of On-line Pharmacies, 1999: Hearing on
On-line Pharmacies Before the Subcomm. on Oversight and Investigations of the House Comm. on
Commerce, 106th Cong. (1999) (statement of Bob Michel, citizen) available in 1999 WL 20010833.
111. See Drugs on the Internet, The Virginian-Pilot and The Ledger-Star, Jan. 2, 2000, at J4.
112. See Shari Roan, Your Friendly Neighborhood E-Drugstore: The New Online Pharmacies
Offer Prompt, Hassle-Free Service, But Health Experts Wony that the Sites Also Pose Serious
Potentialfor Misuse, LA. Times, Sept. 20, 1999, at SI.
113. See Miriam Basch Scott, Online Pharmacies Can Provide Savings, Convenience, Employee
Benefit Plan Rev., Jan. 1, 2000, at 22.
114. See Kim Komando, Things to Know About Online Pharmacies, Ariz. Republic, July 12,
1999, at E2.
115. See Gaw, supra note 101, at IA.
116. See. e.g., drugstore.com (visited Sept. 26, 2000) <http://www. drugstore.com/user/
login.asp?from=/user/modif.accountasp> [hereinafter Create an Account].
117. See, e.g., id.
118. See, e.g., drugstore.com (visited Sept. 26, 2000) <http://www. drugstore.con/pharmacy/
xferins.asp?scripttype=&source=>.
119. See, e.g., drugstore.com (visited Sept. 26, 2000) <http://www. drugstore.com/pharmacy/
healthprofile.aspback=0/o2Fpharmacy%2Fxferdel%2Easp%3Fscripttype%3D%26source%3D%26st
ate%3D&xfer+ 1 &state+>.
120. See, e.g., drugstore.com (visited Sept. 26, 2000) <http://www.drugstore.com/pharmacy/
xferdel.asp?scripttype+&source=&state=>.
121. See, e.g., drugstore.com (visited Sept. 26, 2000) <http://www. drugstore.com/checkoutl
place-order.asp?trx--2308>.
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with credit cards over secured connections on the Internet or via
telephone.12  Several sites offer free mail delivery of prescription
drugs. 23 Customer service representatives and pharmacists generally are
available toll-free via telephone or e-mail twenty-four hours a day to
provide assistance and answer drug-related questions."
After a customer creates an account, there are various methods to
obtain prescription medications from an on-line pharmacist. Prescriptions
can be faxed, mailed, or called to the pharmacy by the physician; a
patient can mail or fax the prescription to the pharmacy; or a patient can
request that a refill be transferred from another pharmacy. 125 Some on-
line pharmacies also accept e-mail prescriptions, but the pharmacy
generally will verify the prescription with the physician.'2 6 For certain
medications with a higher potential for abuse, the on-line pharmacy may
require that the original paper prescription be mailed.2 7
F. Prescription Fraud and On-line Pharmacies
The U.S. government has recognized potential problems with on-line
pharmacies and has proposed regulating on-line drug sales.'28 On-line
pharmacies dispense prescription medications with a potential for
abuse. 129 Because regulation of drug sales is traditionally a state role, 30
gaps exist in the regulation of drug sales caused by variable state
122. See, e.g., Create an Account, supra note 116.
123. See Roan, supra note 104, at F5.
124. See Scott, supra note 113, at 22.
125. See A Tricky Prescription, supra note 9, at C7.
126. See id.
127. See drugstore.com (visited Oct. 27, 2000) <http://www.drugstore.com/pharmacy/
controlledsubs.asp?back=/pharmacy/prices/drugprice.asp?drug=Xanax#procedures>. Schedule II
narcotics, such as Percodan, are not available through drugstore.com. See drugstore.com (visited
Sept. 26, 2000) <http://www.drugstore.com/search/search.asp?searchtype=l&search=percodan>.
128. See Patient Privacy on Web-based Pharmacies Is a Concern, Green Sheet, Mar. 8, 1999,
available in 1999 WL 10793483. Congress commissioned a report to determine the vulnerability of
on-line pharmacies to fraud and deception. See id.
129. These include Schedule III and Schedule IV drugs. See drugstore.com (visited Sept. 26,
2000) <http://www.drugstore.com>; PlanetRx (visited Sept. 26, 2000) <http://www.planetrx.com>.
The National Association of Boards of Pharmacy does not expect on-line pharmacies to distribute
Schedule II drugs because they have a high potential for abuse. See US Govt and Industry Consider
Regulation of On-line Pharmacy, Pharma Marketletter, June 28, 1999, at 12. However, there are no
regulations at this time preventing on-line pharmacies from dispensing Schedule II drugs. See
Blumenschein, supra note 6, at 186.
130. See Sternberg, supra note 105.
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requirements, increasing the potential illegal access to addictive
medications.' In addition, on-line pharmacies vary in their practices for
verifying the legitimacy of prescriptions.' Therefore, state governments
have requested federal regulation of on-line pharmacies by the Food and
Drug Administration (FDA) to help curb illegal on-line drug sales' by
creating civil penalties of up to $500,000 for selling a prescription drug
to a person without a valid prescription. 34
The techniques traditionally used by pharmacists to screen for
prescription fraud are impaired when patients use on-line pharmacies. 35
For example, unlike the community pharmacy setting, on-line
pharmacies lack any direct patient-pharmacist interaction.'36 Thus,
pharmacists cannot observe patient behavior and demeanor to detect
clues of prescription fraud.'37 In addition, no method exists to verify if a
legitimate or fraudulent prescription was sent to numerous on-line
pharmacies. 3
It is also difficult for on-line pharmacists to comply with DEA-
recommended methods'39 to detect prescription fraud. For example,
because on-line pharmacies are often located great distances from the
prescribing physician, the familiarity of pharmacists with the prescribing
habits and signatures of local physicians is absent.40 In addition, patients
can easily circumvent the traditional process used by pharmacists to
verify prescriptions with physicians. 4' For example, when suspicious, a
pharmacist generally will attempt to verify the prescription by calling the
prescribing physician, particularly when the prescription is received via
131. See Robert Pear, U.S. Oversight Soughtfor Online Pharmacies, Austin Am.-Statesman, Dec.
28,1999, atAl.
132. See Suzanne Leigh, Potential for On-line Prescription Fraud Concerns Doctors,
Pharmacists, Fort Worth Star-Telegram, Mar. 26, 1999, at 20A.
133. See FDA Internet Pharmacy Rapid Response Team Featured Under Clinton Initiative,
Health Daily News, Dec. 29, 1999, available in 1999 WL 10485424 (1999).
134. See Clinton to Seek Regulation of Internet Pharmacies, Star Tribune, Minneapolis, Dec. 28,
1999, at A4.
135. See Leigh, supra note 132, at 20A.
136. See id.
137. See A Tricky Prescription, supra note 9, at C7.
138. See Leigh, supra note 132, at 20A.
139. See supra notes 86-90.
140. See Jerry Guidera, Federal Regulators Seek Laws for States to Police On-line Pharmacies,
Dow Jones Business News, July 29, 1999.
141. See Blumenschein, supra note 6, at 186.
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facsimile or telephone. 142 However, physicians are difficult to reach and
pharmacists often speak with another clinic staff member.'43 In sum,
because on-line pharmacies receive prescriptions out of the presence of a
patient and usually a great distance from the prescribing physician, the
verification problems encountered by pharmacists in community
pharmacies are magnified in the on-line pharmacy context.
Finally, anecdotal evidence suggests that it is relatively easy to obtain
medications from some on-line pharmacies without a prescription. This
is particularly true of on-line pharmacies that prescribe and dispense
medications without a patient ever having seen a physician.'" These on-
line pharmacies accept questionnaires completed by patients that are
reviewed by a physician, after which the requested medication is
dispensed.'45 For example, in 1999 Congress heard testimony that
individuals obtained prescription medications from on-line pharmacies
for a cat named "Tom," using the animal's actual height and weight and
obtained a prescription diet drug for a seven-year-old girl using her
actual age.'46
II. DIGITAL SIGNATURE TECHNOLOGY AND GOVERNING
LEGISLATION
Electronic signatures are increasingly used to replace handwritten
signatures. A digital signature is one type of electronic signature that
uses a unique technology to protect the integrity of messages. Most
states, and recently the federal government, have enacted legislation
governing electronic signatures. The Electronic Signatures in Global and
National Commerce Act governs the scope and legal authority of
electronic signatures nationwide. Similarly, the Washington Electronic
Authentication Act establishes the scope and legal authority of digital
signatures in Washington.
142. See id. at 186; see also Keown, supra note 7, at 19.
143. See Blumenschein, supra note 6, at 186.
144. See Congressional Panel Discusses Online Pharmacies, 11 Loy. Consumer L. Rep. 212, 213
(1999).
145. See id.
146. See id.
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A. Digital Signature Technology and Infrastructure
Electronic commerce is one of the fastest growing areas of business
worldwide.47 However, because the Internet allows anonymous access to
cyberspace, it appeals to individuals with dishonorable intentions.'48 In
one study, more than half of the on-line user population polled had
provided false information on-line at some point.'49 Therefore, to recreate
in cyberspace the trust placed in handwritten signatures, electronic forms
of signatures are increasingly used for on-line business and legal
transactions.'5 °
A digital signature is an electronic substitute for a handwritten
signature that is created using a computer instead of a pen.' It is not a
digital replica of a handwritten signature, but rather an unintelligible
string of letters and numbers created by a computer program.'12 To sign a
message digitally requires no technical expertise beyond basic computer
skills.'
Digital signature technology uses cryptography, which is based on the
processes of encrypting and decrypting information. During encryption,
the computer program uses a hash function'54 to convert the original
electronic text of a message into an alternate format, which is then
encrypted with the sender's encryption key.t"' An encryption key,
sometimes called a private key, is merely a computer program that runs
the hash function.'56 The encryption key is unique for each individual
owner and kept confidential.'57 During decryption, the reverse process
147. See John P. Tomaszewski, The Pandora's Box of Cyberspace: State Regulations of Digital
Signatures and the Dormant Commerce Clause, 33 Gonz. L. Rev. 417,420 (1997-1998).
148. See Frank James, Digital Signatures Making Their Mark on Internet Business, Chicago
Tribune, Mar. 29, 1998, at 6.
149. See Kalama M. Lui-Kwan, Recent Developments in Digital Signature Legislation and
Electronic Commerce, 14 Berkeley Tech. L.J. 463,465 (1999).
150. See James, supra note 148, at 6.
151. See Thomas J. Smedinghoff, Electronic Contracts & Digital Signatures: An Overview of
Law and Legislation, 564 PLI/Pat 125, 146 (1999).
152. See id. at 146-47.
153. See id. at 148.
154. A hash is the altered format, consisting of a unique string of letters and numbers, generated
by the automatic mathematical computation of a computer program. See Lui-Kwan, supra note 149,
at 467. A hash function is the conversion of the message to the altered format. See id.
155. See Smedinghoff, supra note 151, at 147.
156. See id
157. See id.
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occurs as the hash is converted back into the text of the original message
using the recipient's decryption key.158 The decryption key, generally
called the public key, can be disclosed to the recipient by attaching it to
the message or by posting it in on-line databases for easy access.'59 If the
hashes match after opening the message with the decryption key, the
message has not been altered since the sender signed it.'
There are two common types of cryptography: symmetric and
asymmetric. Symmetric cryptography uses one secret key for both the
encryption and decryption of messages.' If the secret key is intercepted,
the messages can be easily decrypted, altered, and forwarded without the
knowledge of the sender or intended recipient. 6  Asymmetric
cryptography is a more secure type of cryptography that requires a
unique key pair consisting of one private and one public key. 63 Only the
keys in a given pair function together." The key pair owner keeps the
private key confidential and uses it to encrypt messages to be opened by
a recipient possessing the corresponding public key, which is usually
attached to the message when sent.65
Asymmetric cryptography offers a high level of certainty that the
holder of the private key sent the encrypted message and that the
encrypted message has not been altered since it was generated.'66 As long
as the owner protects access to the private key, messages encrypted using
the private key are verifiably written by the private-key owner.'67 In
addition, by decrypting the message using the corresponding public key,
the recipient can determine if the message was altered in any way since
its generation.' 68
158. See Lui-Kwan, supra note 149, at 467-68.
159. See Smedinghoff, supra note 151, at 147.
160. See Lui-Kwan, supra note 149, at 467.
161. See whatis.techtarget.com (visited Sept. 26, 2000) <http://whatis.techtarget.com/
Whatls DefinitionPage/ 0,4152,214299,00.html> (defining PKI).
162. See id.; see also Lonnie Eldridge, Comment, Internet Commerce and the Meltdown of
Certification Authorities: Is the Washington State Sohtion a Good Model?, 45 UCLA L. Rev. 1805,
1811 (1998).
163. See Smedinghoff, supra note 151, at 148.
164. See id.
165. See Lui-Kwan, supra note 149, at 467.
166. See Smedinghoff, supra note 151, at 147.
167. See id. at 147, 149.
168. See id. at 147.
1348
Vol. 75:1331, 2000
On-line Pharmacies and E-SIGN
Certification authorities'69 issue digital certificates 7 ' that include
asymmetric cryptographic key pairs. 7 ' Depending on state statutes, a
certification authority may be a state agency or a private entity.'72 A
subscriber contacts a certification authority to obtain the digital
certificate and corresponding asymmetric key pair.'73 The certification
authority verifies the subscriber's identity itself 74 or by using a
registration authority. 7 ' A registration authority is usually a component
of a licensed certification authority and verifies the information of an
individual seeking a digital certificate.'76 Once .the subscriber's
information has been verified, the certification authority issues a digital
certificate with a corresponding asymmetric key pair.'77 The digital
certificate is stored in a directory, known as a repository, where
recipients of messages can verify on-line the identity of the public key
owner. 1
78
A digital certificate establishes an individual's credentials to use a
given asymmetric cryptographic key pair. 79 Digital certificates contain
the individual's name, a corresponding serial number, the expiration date
of the certificate, and a copy of the public key belonging to the
169. See id. at 149. A certification authority issues security credentials and public keys for
message encryption and decryption as part of a public key infrastructure (PKI). The entities and
processes required to obtain and use a digital signature based on asymmetric cryptography are
known as a PKI. See whatis.techtarget.com (visited Sept. 26, 2000) <http://whatis.techtargetcom/
WhatlsDefinitionPage/0,4152,214299,00.html> (defining. PK1). Private corporations support the
PKI infrastructure, including RSA (a developer of algorithms used in PKI technology) and Verisign
(a certification authority and a company that sells software that allows other companies to create
their own certification authorities). See Id.
170. See Smedinghoff, supra note 151, at 149. A digital certificate establishes an individual's
credentials for transactions on the Interet. Usually, it is maintained in an on-line database for public
reference. See id. at 151; see also infra notes 179-182.
171. See Smedinghoff, supra note 151, at 149.
172. See Thomas J. Smedinghoff, Overview of State Electronic and Digital Signature Legislation,
Oil Glass-CLE 237, 245-55 (1998).
173. See Smedinghoff, supra note 151, at 149.
174. At least one Internet site offers a uniform application method to streamline the process of
obtaining a certificate in participating states. See The Uniform Certificate of Authority Application
(visited Sept. 26,2000) <http://www.naic.orgtucaa/>.
175. See whatis.techtarget.com (visited Sept. 26, 2000) <http://whatis.techtarget.com/Whatls_
Definition_Page/0,4152,214245,00.html> (defining RA).
176. See id.
177. See Smedinghoff, supra note 151, at 150.
178. See id. Repositories store other information regarding the subscriber and the status of the
digital certificate (e.g., suspended or revoked). See id.
179. See id.
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certificate's owner."' A digital certificate also includes the digital
signature of the certification authority that issued it.' Thus, the recipient
of a message with a digital signature can contact a repository of digital
signatures to verify that the certificate and associated public key is
correct. '
82
B. The Electronic Signatures in Global and National Commerce Act
The federal government recently enacted the Electronic Signatures in
Global and National Commerce Act (E-SIGN),' 83 ensuring that electronic
signatures are not denied legal recognition merely because they are in an
electronic form."s Although most states have enacted legislation to give
legal recognition to certain types of electronic signatures,8 5 E-SIGN was
enacted to create a uniform nationwide standard governing electronic
signatures. 186 E-SIGN generally applies to all types of communications,
with some exceptions. 7 However, E-SIGN does not require individuals
to use or accept electronic signatures.'
E-SIGN is technology neutral because it prohibits requiring the use of
a specific type of electronic signature technology.'89 E-SIGN prohibits
statutes or regulations that deny the legal validity of an electronic
signature based on the type of technology used.' 90 E-SIGN's definition of
an electronic signature is also technology neutral, defining it as
180. See id.
181. See James, supra note 148, at 6.
182. See Smedinghoff, supra note 151, at 150.
183. See Pub. L, No. 106-229, 114 Stat. 464 (2000).
184. See Pub. L. No. 106-229, § 101(a), 114 Stat. 464,464.
185. See Lui-Kwan, supra note 149, at 472.
186. See S. Rep. No. 106-13 1, at 1 (1999). The legislative history indicates that Congress believed
a uniform national standard would encourage electronic commerce through the operation of free-
market forces, while promoting public confidence in the validity of electronic commerce itself. See
H.R. Rep. No. 106-341, pt. 2, at 2-3 (1999).
187. In part, E-SIGN does not apply to wills, adoptions, divorce, state actions that do not affect
interstate commerce, official court documents, and the cancellation of health care benefits. See Pub.
L. No. 106-229, § 103, 114 Stat. 464, 468. However, E-SIGN does apply to prescriptions. See Pub.
L. No. 106-229, § 103, 114 Stat. 464, 468. E-SIGN's applicability to prescriptions is important
because a valid prescription requires a legally valid signature by an individual authorized to
prescribe medications. See Wash. Rev. Code § 18.71.021 (1998); see also Wash. Rev. Code
§ 18.71.011(2) (1998).
188. See Pub. L. No. 106-229, § 101(b)(2), 114 Stat. 464,464.
189. See Pub. L. No. 106-229, § 102(a)(2)(A)(ii), 114 Stat. 464, 468.
190. See Pub. L. No. 106-229, § 102(a)(2)(A)(ii), 114 Stat. 464, 468.
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information in an electronic form that is "attached to or logically
associated with an electronic record," and used by an individual with the
intent to sign a document' 9 ' This allows parties to a transaction to
determine the electronic signature technology they will use.92
Federal and state statutes or regulations must be consistent with E-
SIGN.' This requirement will preempt any state laws that mandate the
use of electronic signatures or require the use of a specific type of
technology."9 Although E-SIGN preserves the existing rulemaking
authority of state regulatory agencies pursuant to other statutes,
promulgated regulations must be consistent with E-SIGN, technology
neutral, and not additions to E-SIGN's requirements.' For example, E-
SIGN permits states to modify E-SIGN's requirements through statutes
and regulations by adopting the Uniform Electronic Transactions Act
(UETA).t96 UETA is consistent with E-SIGN because it is technology
neutral and does not require the use of electronic signatures.'97
C. The Washington Electronic Authentication Act
The Washington Legislature enacted the Washington Electronic
Authentication Act (WEAA) in March 1996.' WEAA is one of the most
comprehensive and advanced statutes governing electronic signatures ion
the United States. t99 Like E-SIGN, WEAA ensures that digital signatures
are not denied legal recognition solely because they are in electronic
form."0 However, unlike E-SIGN, WEAA uses the term "digital
signature" instead of electronic signature and defines it as an
191. Pub. L. No. 106-229, § 106(5), 114 Stat. 464,472.
192. See New Electronic Signatures Law, Mondaq Bus. Briefing, Aug. 11, 2000, at 1, available in
2000 WL 92387510.
193. See Pub. L. No. 106-229, § 102(a)(2)(A)(i), 114 Stat. 464, 468.
194. See Pub. L. No. 106-229, §§ 101(a)(2), 102(a)(2)(A)(ii), 114 Stat. 464,468.
195. See Pub. L. No. 106-229, § 104(b), 114 Stat. 464,469 (2000).
196. See Uniform Electronic Transactions Act (1999).
197. See Uniform Electronic Transactions Act § 2(8) (1999). Other components of the Uniform
Electronic Transactions Act are alternately more and less comprehensive than E-SIGN. See
generally Uniform Electronic Transactions Act (1999).
198. See 1996 Wash. Laws 250. The Act was implemented partially on July 27, 1997, and fully
on January 1, 1998. See Wash. Rev. Code § 19.34.901 (1998).
199. See Eldridge, supra note 162, at 1828. Washington modeled WEAA on Utah Code
Annotated §§ 46-3-101 to -504 (1997), which is a model statute for governing digital signatures. Id.
at 1828 n.90.
200. For a listing of additional purposes of WEAA, see Wash. Rev. Code § 19.34.010 (1998).
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asymmetric-cryptographic system.2°' WEAA applies generally to all
types of communications.2 2 Compliance with WEAA is voluntary.0 3
However, failure to comply with WEAA jeopardizes the legal status of a
digital signature.2 4
WEAA establishes the legal status of a digital signature obtained in
compliance with the statute. WEAA states that "[w]here a rule of law
requires a signature, or provides for certain consequences in the absence
of a signature, that rule is satisfied by a digital signature" when three
factors are met.2 5 First, the "digital signature is verified by reference to
the public key listed in a valid certificate issued by a licensed
certification authority. 2 6 Second, the digital signature must have been
used with the intention of signing the message.2 7 Third, the "recipient of
the message must have no knowledge or notice that the signer either
breached a duty" in obtaining the certificate or "[d]oes not rightfully hold
the private key used to affix the digital signature.
208
Under WEAA, an individual applying for a digital certificate is called
a subscriber and must provide a licensed certification authority with
specific information for confirming the subscriber's identity prior to
issuing a digital certificate. 29 The licensed certification authority must
make a reasonable inquiry into the information provided by each
subscriber.210 When a subscriber accepts a certificate issued by a licensed
certification authority under WEAA, the subscriber has a duty to use
reasonable care to control access to the private key and prevent its
disclosure to someone not authorized to use the subscriber's digital
signature.21' A private key is the personal property of the subscriber.
2I 2
201. See Wash. Rev. Code § 19.34.020(11) (1998).
202. Examples include communications between business, consumer, legal, governmental, and
other types of entities. See Wash. Rev. Code § 19.34.010(3).
203. See Wash. Rev. Code § 19.34.010(3).
204. See infra note 201.
205. Wash. Rev. Code § 19.34.300 (1998).
206. Wash. Rev. Code § 19.34.300(1)(a).
207. See Wash. Rev. Code § 19.34.300(1)(b).
208. Wash. Rev. Code § 19.34.300(1)(c). The recipient of a message signed with a digital
signature "assumes the risk that the signature was forged" if that individual's reliance "is not
reasonable under the circumstances." Wash. Rev. Code § 19.34.310 (1998).
209. See Wash. Rev. Code § 19.34.210(1) (1998).
210. See Wash. Rev. Code § 19.34.210(2) (1998). The reasonableness of the inquiry depends on
the quality of statements the certification authority will later make regarding the reliability of the
certificate, the reliance limit of the certificate, and the recommended uses of the certificate.
211. See Wash. Rev. Code § 19.34.240(l) (1998).
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Thus, because WEAA has more technical requirements than E-SIGN it
provides more opportunities for combating prescription fraud.
III. E-SIGN INCAPACITATES WEAA AS A TOOL TO COMBAT
PRESCRIPTION FRAUD AGAINST ON-LINE PHARMACIES
E-SIGN restricts Washington's ability to implement a comprehensive
and effective program to combat prescription fraud against on-line
pharmacies. E-SIGN preempts WEAA's asymmetric cryptography
requirement and prohibits requiring that on-line pharmacies only receive
prescriptions transmitted electronically. Thus, E-SIGN inhibits
Washington's ability to protect the public's health, safety, and welfare
from the harms of prescription fraud against on-line pharmacies.
A. E-SIGNPreempts WEAA's Asymmetric-Cryptography Requirement
E-SIGN preempts a fundamental strength of WEAA, the requirement
that electronic signatures in Washington use asymmetric cryptography.
E-SIGN is technology neutral and preempts statutes and regulations that
discriminate for or against a particular type of electronic signature
technology."1 3 Because it is inconsistent with E-SIGN, WEAA's
asymmetric-cryptography requirement 14 could be invalidated. Thus,
without WEAA's asymmetric-cryptography requirement, E-SIGN vests
legal status in electronic signatures that are less secure than a
handwritten signature because E-SIGN lacks any requirement that an
electronic signature be secure from even the simplest fraud.2"'
E-SIGN significantly reduces the relative advantage of WEAA over
other state statutes governing electronic signatures for combating
prescription fraud against on-line pharmacies. Statutory schemes that do
not use asymmetric cryptography are less secure against undetected
212. See Wash. Rev. Code § 19.34.240(2) (1998).
213. See Electronic Signatures in Global and National Commerce Act, Pub. L. No. 106-229,
§ 102(a)(2)(A)(ii), 114 Stat. 464,468 (2000).
214. See Wash. Rev. Code § 19.34.020(11) (1998).
215. See Paul Hoffman, The Pen Is Mightier Than the Electronic Signature, Network World, July
24, 2000, at 41, available in 2000 WL 9435775. At least one commentator equates an electronic
signature without asymmetric cryptography or other security technology to an oral contract, arguing
that either party to the transaction can later claim that what was sent is different than the copy kept in
a computer hard drive. See id. The lack of security is a high price to pay for Congress's desire to
promote new electronic signature technologies, regardless whether they meet the basic security
needs of future users. Cf H.P. Rep. No. 106-341, pt. 1, at 8 (1999).
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interception and alteration prior to delivery to the intended recipient.1 6
Unable to require asymmetric cryptography, Washington and other states
must now permit individuals to use technologies that are less secure
against forgery for electronically transmitting prescriptions. For example,
a prescription sent electronically to an on-line pharmacy using symmetric
cryptography 217 could be easily altered and forwarded without the
knowledge of either the original sender or the receiving pharmacist.
E-SIGN ensures new opportunities to transmit prescriptions electron-
ically without an assurance of the authenticity of the prescription's
content and author. Without the use of asymmetric cryptography, on-line
pharmacists will be unable to determine if the contents of an
electronically transmitted prescription have been altered since being
signed by a physician. 218 Similarly, on-line pharmacists will be unable to
determine accurately from the electronic prescription itself if the
electronic signature belongs to the physician who purportedly
electronically signed and sent the prescription to the pharmacy.29 By
preempting WEAA's asymmetric-cryptography requirement, E-SIGN
actually reduces the effectiveness of electronic signatures for preventing
prescription fraud against on-line pharmacies.
B. E-SIGN Precludes the Ability of States To Require that On-line
Pharmacies Only Receive Prescriptions Transmitted Using Digital
Signatures
E-SIGN frustrates attempts to combat fraud by prohibiting states from
requiring the use of electronic signatures. E-SIGN does not require
individuals to use or accept electronic signatures and prohibits state
statutes and regulations from requiring the use or acceptance of
electronic signatures. 220 Prior to E-SIGN, statutes such as WEAA could
have been amended to require that on-line pharmacies only accept
prescriptions electronically. Now, E-SIGN prohibits states from enacting
such statutes or regulations because they would be inconsistent with E-
SIGN.2 State pharmacy boards, therefore, no longer have the power to
require that on-line pharmacies only accept prescriptions transmitted
216. See supra note 161 and accompanying text (defining symmetric cryptography).
217. See id.
218. See supra note 168 and accompanying text.
219. See supra note 167 and accompanying text.
220. See Pub. L. No. 106-229, § 101(b)(2), 114 Stat. 464 (2000).
221. See Pub. L. No. 106-229, § 102(a)(2)(A)(i), 114 Stat. 464, 468 (2000).
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using electronic signatures. By limiting the traditional role of pharmacy
boards, E-SIGN diminishes the effectiveness of statutes like WEAA for
combating prescription fraud against on-line pharmacies.
E-SIGN reinforces on-line pharmacies as unique targets of
prescription fraud. On-line pharmacists will remain unable to detect and
prevent fraudulent paper or electronic prescriptions. On-line pharmacies
are poorly situated to detect prescription fraud using the traditional
methods available to community pharmacists.' On-line pharmacists are
unable to observe a patient's behavior directly for cues that a prescription
is fraudulent. They are unable to verify if a prescription has been sent to
numerous on-line pharmacies. In addition, on-line pharmacies are unable
to comply fully with DEA-recommended methods to detect and prevent
prescription fraud.' Therefore, on-line pharmacies remain a uniquely
vulnerable target of prescription fraud through traditional methods such
as altering or forging paper prescriptions, or new methods of electronic
fraud.
C. E-SIGN Threatens Washington 's Ability to Protect the Public's
Health, Safety, and Welfare Related to Prescription Fraud Against
On-line Pharmacies.
E-SIGN inhibits the efforts of state agencies charged with protecting
the public's health, safety, and welfare. The Washington State Board of
Pharmacy is authorized by statute to promulgate regulations for the
protection and promotion of the public's health, safety, and welfare. 4
Public policy warrants strengthening safeguards against prescription
fraud by requiring the use of digital signatures for all prescriptions
dispensed by on-line pharmacies. Because prescription drug abuse is a
serious and sometimes deadly threat to the health of many Americans,
225
the Board of Pharmacy must be able to prevent prescription fraud.
Requiring electronic signatures is one way the Board could combat
prescription fraud against on-line pharmacies. Therefore, sufficient
controls are necessary to erect a barrier to obtaining prescription
medications fraudulently from on-line pharmacies. However, the Board
of Pharmacy cannot implement via regulation a comprehensive and
222. See supra notes 135-38 and accompanying text.
223. See supra note 86 and accompanying text.
224. See Wash. Rev. Code § 18.64.005 (1998).
225. See supra notes 21-30.
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effective program because E-SIGN preempts WEAA's asymmetric-
cryptography requirement and prohibits requiring that on-line
pharmacies only receive prescriptions transmitted using electronic
signatures. Thus, E-SIGN threatens the public's health, safety, and
welfare by prohibiting actions by state agencies that would nearly
eliminate prescription drug fraud against on-line pharmacies.
IV. OPTIONS AFTER E-SIGN FOR COMBATING PRESCRIPTION
FRAUD AGAINST ON-LINE PHARMACIES IN
WASHINGTON
Despite its restrictions, E-SIGN allows some options to combat
prescription drug fraud against on-line pharmacies. Washington should
require that all prescriptions dispensed by on-line pharmacies and paid
for with public funds be transmitted electronically using asymmetric-
cryptography technology. This requirement would encourage the on-line
pharmacy industry to move toward self-regulation by accepting
prescriptions only transmitted electronically using such technology.
However, such self-regulation is unlikely to develop because of industry
concerns regarding perceived barriers for consumers to access on-line
pharmacies. Moreover, self-regulation without a comprehensive statutory
framework will achieve only limited success in preventing prescription
fraud against on-line pharmacies.
A. Washington Should Deny State Funds to On-line Pharmacies that
Do Not Accept Only Prescriptions Transmitted Electronically
Using Asymmetric-Cryptography Technology
The Washington Legislature should require that all prescriptions
dispensed by on-line pharmacies and paid for with public funds be
transmitted electronically using asymmetric-cryptography technology.
Under E-SIGN, states as market participants are not restricted from
according a greater legal status to a specific electronic signature
technology.2 26 Washington is a market participant because, under the
state's Medical Assistance Program, Washington pays for prescription
medications that provide health care benefits for more than 700,000 low-
income, disabled, or pregnant Washington residents.227 By requiring the
226. See Pub. L. No. 106-229, § 102(b), 114 Stat. 464, 468.
227. See Medical Assistance Administration (visited Sept. 26, 2000) <http://www.wa.gov/dshs/
rial/maa2/maa3ov.html>.
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electronic transmission of prescriptions using asymmetric-cryptography
technology for payment of prescriptions with state Medical Assistance
funds, Washington would prevent the abuse of state funds for fraudulent
prescriptions sent to on-line pharmacies. Therefore, Washington can
mandate certain requirements before disbursing state funds for
prescriptions dispensed by an on-line pharmacy.
B. The On-line Pharmacy Industry Should Voluntarily Mandate that
All Prescriptions Be Transmitted Electronically Using Asymmetric
Cryptography-Technology
E-SIGN relies on the market rather than government regulation to
define both who will use electronic signatures and the type of electronic
signature technology those individuals will choose.228 This approach
favors voluntary solutions between private parties to the use of electronic
signatures. On-line pharmacies should voluntarily require that all
prescriptions received be signed using an electronic signature capable of
authenticating the author's identity and verifying that the prescription's
content has not been altered since signed. 9 At a minimum, this approach
would deter prescription fraud perpetrated using paper prescriptions.
However, the industry is unlikely to implement this requirement
voluntarily because of perceived barriers to obtaining customers.
Moreover, such a standard would be only marginally effective at
eliminating on-line prescription fraud absent a comprehensive statutory
framework. Thus, E-SIGN fails to encourage the type of voluntary use of
electronic signatures by industries it purports to prefer.
228. See Federal Courts and the Internet, 2000: Hearing on Electronic Signature Legislation
Before the Subcomm. on Courts and Intellectual Property of the House Judiciary Comm., 106th
Cong. (2000) (statement of the Honorable Andrew J. Pincus), available in 2000 WL 23831150, at
*12.
229. Ultimately, all pharmacies, including community and mail-order businesses, should
implement an electronically transmitted and digitally signed requirement for all prescriptions filled.
The harm caused by prescription drug abuse and diversion results from prescription fraud
perpetrated against all types of pharmacies. However, this Comment recognizes that not all patients
have access to computers to open on-line pharmacy accounts and order refills, particularly the
elderly and patients with limited incomes. Although some patients can access computers at public
libraries or cyber cafes (coffee shops offering Internet access), others may live in remote areas or
lack the time, motivation, or knowledge to access the Internet. Until such access concerns can be
adequately addressed, these recommendations should only apply to on-line pharmacies.
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1. The Favorable Consequences of Self-Regulation by the On-line
Pharmacy Industry.
Self-regulation by the on-line pharmacy industry would promote
industry growth by increasing consumer confidence and encouraging
more use of on-line pharmacies. 3 ' Some on-line pharmacy executives
are already voluntarily seeking heightened regulation of on-line phar-
macies."' Proactive implementation of voluntary standards, which
protect the public and legitimize the industry, would help minimize the
potential costs of compliance with government regulations that would
otherwise be imposed as the on-line pharmacy industry matures. Any
future regulation likely will occur in response to public concern that on-
line pharmacies fail to protect adequately against prescription fraud and
subsequent harms. Imposed regulations may be reactionary in nature,
resulting in more restrictive constraints on the industry.
By voluntarily adopting digital signatures as the industry standard, on-
line pharmacies would obtain several long-term benefits, despite the
possibility of an initial short-term decrease in prescription orders. First,
on-line pharmacies would gain an enhanced image of trustworthiness
among more consumers if they accepted only prescriptions using digital
signatures. Consumer perceptions of trustworthiness and convenience are
crucial factors for attracting new customers to on-line pharmacies from
the more familiar community pharmacy experience. 32 On-line pharmacy
executives already recognize the value of positive consumer
perceptions. 233 Self-regulation would create an image of on-line
pharmacies as a trustworthy alternative to community pharmacies,
evidenced by the concern of on-line pharmacies for patient welfare and
safety. For example, on-line pharmacies could tout the use of digital
signatures as a means to reduce prescription errors commonly caused by
illegible handwritten prescriptions and responsible for significant harm to
patients.3 Second, if all prescriptions were received electronically, the
230. See President Clinton's Initiative To Oversee Online Pharmacies Will Spur Growth, Info-
Tech Chief Says, PR Newswire, Jan. 6, 2000 [hereinafter President Clinton s Initiative].
231. See Roan, supra note 112, at S 1.
232. See supra notes 102, 106 and accompanying text.
233. See President Clinton's Initiative, supra note 230 and accompanying text.
234. See Drugstores on the Net: The Benefits and Risks of On-line Pharmacies, 1999: Hearing on
On-line Pharmacies Before the Subcomm. on Oversight and Investigations of the House Comm. on
Commerce, 106th Cong. (1999) (statement of Dr. Herman Abromowitz, American Medical
Association), available in 1999 WL 20010892, at *13. The American Medical Association supports
1358
Vol. 75:1331, 2000
On-line Pharmacies and E-SIGN
cost to the on-line pharmacy of verifying and processing prescriptions
using other methods would be nearly eliminated, thereby decreasing
operating costs, improving profitability, and increasing competitiveness
based on price. On-line pharmacies already have begun to compete in
offering the least expensive prices," which will be increasingly
important in securing contracts with large health care payers."
2. The On-line Pharmacy Industry Is Unlikely To Engage in Self-
Regulation that Constrains Its Business Objectives in Order To
Protect the Public's Health
Despite these benefits, the on-line pharmacy industry is unlikely to
mandate voluntarily that its pharmacies only receive prescriptions
transmitted electronically using asymmetric-cryptography technology.
Such a standard would threaten industry access to consumers by creating
additional barriers to using on-line pharmacies. Although minimal,
asymmetric cryptography requires that time and money be spent
obtaining the public-private key pair." Those choosing not to obtain
asymmetric key pairs could not use an on-line pharmacy. In the highly
competitive on-line marketplace, barrier-free access to consumers is
crucial to ensure the success of newly emerging businesses." Thus, the
on-line pharmacy likely will not voluntarily implement this requirement.
However, it is plausible that patient and health care payer demand
could overcome potential obstacles caused by physicians not yet having
adopted digital signature technology. More than 22 million consumers
accessed the Internet for health and medical information in 1998. 9 More
importantly, large health care payers such as managed-care organi-
zations, pharmacy benefit managers,240 and self-funded employers24'
on-line transmission of prescriptions to pharmacies to reduce errors caused by a failure to understand
handwritten prescriptions. See id
235. See The BigRr.com to Offer Nutraceuticals and Consumer Information, Tan Sheet, Aug. 2,
1999, available in 1999 WL 21327114, at *1.
236. See infra notes 242-43 and accompanying text.
237. See supra notes 169-77 and accompanying text.
238. See supra notes 110-13 and accompanying text.
239. See Congressional Panel Discusses Online Pharmacies, supra note 144, at 212.
240. Pharmacy benefit managers control the costs of providing prescription medications to a
defined population of patients by negotiating rebate contracts with drug manufacturers, establishing
reimbursement rates for pharmacy network providers, and entering into drug risk-sharing
arrangements with physician groups for the cost of medications prescribed. See Helene Levens
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recognize the cost savings available from on-line pharmacies because of
lower overhead. 42 For example, during 1999, one pharmacy benefit
manager with more than 47 million patients, for whom the manager
purchased more than $10 billion worth of prescription medications per
year, contracted with an on-line pharmacy to reduce the cost of providing
prescription medications. 43 Thus, the minimal investment required by
physicians to obtain an electronic signature for use with on-line
pharmacies would be offset by the ability of physicians to offer a service
in demand by both their patients and health care payers.
Furthermore, because most physicians have integrated the use of
electronic communication technology into their practices, it is reasonable
to expect physicians to use electronic signatures to send prescriptions to
on-line pharmacies with great efficiency. In fact, the electronic exchange
of medical information is a rapidly expanding trend in the medical
profession.4 For example, physicians increasingly interact with patients
using e-mail.245 Some physicians provide basic diagnostic and treatment
services on-line.246 In addition, because handwritten prescriptions are
time-consuming and costly, new software products exist that allow
physicians to complete and transmit electronic prescriptions directly
from the treatment room.247 Further, some pharmacies have begun testing
programs to accept electronic prescriptions sent directly from physicians
to pharmacists.248
Lipton et al., Medicare Dnig Benefit: Managing The Pharmacy Benefit in Medicare HMOs: What
Do We Really Know?, Health Affairs, Mar.-Apr. 2000, at 42.
241. Some employers choose to pay for all their employee health care claims out-of-pocket, as is
authorized by ERISA. See Employee Retirement Income Security Act of 1974, 29 U.S.C. §§ 1001-
1191(c) (1994).
242. See Rx.com CEO Calls for the Creation of Internet Pricing Guidelines for Reimbursement of
Pharmaceutical Costs; New Plan Aims To Reduce Managed Care Costs for Online Prescriptions,
Bus. Wire, Jan. 13, 2000.
243. See Larry Holyoke, Express Scripts Has Prescription for the Internet, St. Louis Bus. J., July
5, 1999, at IA.
244. See Ranney V. Wiesemann, On-line or On-call? Legal and Ethical Challenges Emerging in
Cybermedicine, 43 St. Louis U. L.J. 1119, 1121 (1999).
245. See id. at 1120.
246. See id. at 1138-39.
247. See ePhysician to Participate in New drugstore.com Certification Program for Electronic
Prescriptions, Bus. Wire, Nov. 4, 1999.
248. See Walgreen Co. v. Wisconsin Pharmacy Examining Bd., No. 97-1513, 1998 WL 65551
(Wis. Ct. App. Feb. 19, 1998) (holding that electronic transmission of prescriptions directly from
physician to pharmacist did not violate regulatory statutes and administrative rules governing
Wisconsin pharmacies).
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Nonetheless, because E-SIGN is technology neutral and prohibits
contradictory statutes and regulations, the on-line pharmacy industry
likely will choose the technology most suitable to expanding its business
transactions. The industry likely will not choose the technology that best
protects the public's health, safety, and welfare. Rather, the on-line
pharmacy industry is likely to choose the technology that is least costly
and most efficient. E-SIGN might encourage the development of new
forms of electronic signature technology, however, it will not encourage
parties to choose the best technology for preventing prescription fraud.
3. The Limitations of Self-Regulation by the On-line Pharmacy Industry
Self-regulation by the on-line pharmacy industry is less effective than
a comprehensive statutory framework, which would close the loopholes
to prescription fraud against on-line pharmacies. Even if the industry
adopted asymmetric-cryptography technology, a pharmacist receiving a
prescription electronically could only determine the identity of the sender
and that the contents of the message had not been altered.249 Thus, the
pharmacist would not be certain that the sender was licensed to prescribe
medications because such information would not be inherent in the
electronic signature.' 0 To address this shortcoming, WEAA could have
been amended to invalidate any prescriptions transmitted electronically
to Washington on-line pharmacies using electronic signatures not
veriflably owned by an individual authorized to prescribe medications."
However, E-SIGN likely prohibits such an amendment."2 Thus, self-
regulation is powerless to close the loopholes of asymmetric-
cryptography technology.
Under E-SIGN, it is unlikely that WEAA could be amended to create
a class of electronic signatures solely authorized to prescribe medications
electronically. E-SIGN preempts statutes or regulations that accord a
greater legal status or effect to a specific technology or technical
249. See supra notes 166-68 and accompanying text.
250. See id.
251. This would have required that all digital certificates issued by licensed certification
authorities indicate whether the owner of any asymmetric key pair was licensed to prescribe
medications. Under this scheme, after receiving a prescription signed with a digital signature,
pharmacists could not only verify the identity of the sender of the prescription and if it had been
altered since signed, but also determine whether the sender is licensed to prescribe medications.
252. See supra notes 220-21 and accompanying text.
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specification.253 Creating a unique class of electronic signatures solely
authorized to prescribe medications electronically would enhance the
legal status of that type of electronic signature. Such an action, whether
by amendment or regulation arguably would violate E-SIGN's
prohibition against favoritism.
Finally, self-regulation is largely industry specific. Pharmacies cannot
regulate doctors and doctors cannot regulate pharmacies; only
governments can regulate both. Thus, on-line pharmacies requiring all
prescriptions to be received electronically using asymmetric-
cryptography technology would not ensure that physicians would
exercise reasonable care to maintain the security of electronic signatures.
Theoretically, a third party could obtain a physician's private key to
obtain prescription medications illegally. WEAA creates a duty that the
owner of an asymmetric cryptographic key pair exercise reasonable care
to maintain the security of the private key.2 4 However, WEAA is silent
regarding the consequences if the owner breaches this duty.255 Assuming
E-SIGN preempts WEAA's asymmetric-cryptography system, no
effective incentives remain to ensure that physicians electronically
prescribing medications restrict access to their electronic signatures. E-
SIGN will thus await the efforts of two industries where WEAA had
already accounted for both.
Existing legal incentives for physicians to restrict access to their
electronic signatures capable of prescribing medications are insufficient.
Tort liability creates little or no incentive for physicians because
defendants are generally not liable for the results of intervening criminal
acts when no reasonable level of care by the defendant would prevent the
subsequent harm. 256 Because in Washington it is unlawful for any person
knowingly or intentionally to forge a prescription211 or possess a false or
fraudulent prescription with intent to obtain a controlled substance,258
physicians likely would not be liable in tort for any harms caused by the
unauthorized use of their digital signatures.
253. Pub. L. No. 106-229, § 102(2)(A)(ii), 114 Stat. 464,468 (2000).
254. See Wash. Rev. Code § 19.34.240(1) (1998).
255. See Wash. Rev. Code § 19.34.240 (1998).
256. See W. Page Keeton, Prosser and Keeton on Torts 313 (5th ed. 1984); see also, e.g., Guy v.
McKenzie, 394 S.E.2d 576, (Ga. Ct. App. 1990) (holding pharmacist not negligent for failing to
prevent employee from removing controlled substances that employee sold to motorist who later
suffered injuries in accident caused by ingesting those controlled substances).
257. See Wash. Rev. Code § 69.50.403(a)(5) (1998).
258. See Wash. Rev. Code § 69.50.403(a)(8) (1998).
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Washington could amend WEAA to create an incentive for physicians
to restrict access to their electronic signatures -capable of prescribing
medications. One option would be to tie the privilege of possessing a
state medical license to the duty to restrict access to electronic signatures.
By breaching this duty, a physician's capacity to prescribe medications
could be limited by state medical boards. State boards of medicine and
pharmacy would likely support this amendment because both are
concerned that existing enforcement mechanisms are inadequate to
police the on-line environment.29 E-SIGN would allow this amendment
because it would not conflict with the provisions of E-SIGN,2 ° nor
would it give greater legal status to a specific type of technology.26'
However, the ability to restrict access to an electronic signature is not
practical under E-SIGN. Electronic signature technology that is not based
on asymmetric cryptography does not provide a private key realistically
capable of being kept secret.262 It would be inappropriate to sanction
physicians for the unauthorized use of other types of electronic
signatures because those technologies are not reasonably secure from
forgery, regardless of a physician's efforts to prevent its unauthorized
use. Physicians could not meet their statutory duty to exercise reasonable
care to maintain the security of their non-asymmetric technology
electronic signatures. This frustration of possible incentives merely
demonstrates another way in which E-SIGN will impede state efforts to
combat on-line prescription fraud.
V. CONCLUSION
Prescription drug abuse and fraud are significant problems in the
United States. Although prescription medications are regulated,
individuals often obtain drugs fraudulently to maintain their own
addictions or divert the drugs for illegal sale on the street. On-line
pharmacies are particularly vulnerable to prescription fraud because of
the limited ability of on-line pharmacists to employ traditional methods
of detecting fraud in community pharmacies.
259. See Drugstores on the Net: The Benefits and Risks of On-line Pharmacies, 1999: Hearing on
On-line Pharmacies Before the Subcomm. on Oversight and Investigations of the House Comm. on
Commerce, 106th Cong. (1999) (statement of Jody Bernstein, Director of the Bureau of Consumer
Protection, Federal Trade Commission) available in 1999 WL 20010888, at *5.
260. See Pub. L. No. 106-229, § 102(a)(2)(A)(i), 114 Stat. 464,468 (2000).
261. See Pub. L. No. 106-229, § 102(a)(2)(A)(ii), 114 Stat. 464,468 (2000).
262. See supra notes 161-62 and accompanying text.
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The Electronic Signatures in Global and National Commerce Act (E-
SIGN) ensures that electronic signatures are not denied legal recognition
merely because they are in an electronic form. E-SIGN does not require
individuals to use or accept electronic signatures and preempts other laws
that contradict its provisions. The Washington Electronic Authentication
Act (WEAA) also ensures that digital signatures are not denied legal
recognition solely because they are in electronic form. WEAA is one of
the most comprehensive and advanced statutes governing digital
signatures because it requires the use of asymmetric-cryptography
technology.
E-SIGN frustrates Washington's ability to protect the public's health,
safety, and welfare from the harms of prescription fraud against on-line
pharmacies. Prior to E-SIGN, WEAA was a strong framework, which,
once amended, could have been used as a comprehensive and effective
mechanism that would have nearly eliminated this problem. However, E-
SIGN will likely preempt WEAA's asymmetric-cryptography require-
ment and it prohibits amending WEAA to require that on-line
pharmacies receive only prescriptions transmitted electronically. These
provisions are necessary to combat this problem and nearly eliminate
prescription fraud against on-line pharmacies.
In the wake of E-SIGN, Washington should prohibit expenditures of
state Medical Assistance funds to pay for prescriptions dispensed by on-
line pharmacies that do not receive only prescriptions transmitted
electronically using asymmetric-cryptography technology. In addition,
the on-line pharmacy industry should voluntarily require that members
receive only prescriptions transmitted electronically using asymmetric-
cryptography technology. However, self-regulation is unlikely because
of industry concerns regarding perceived barriers for consumers to
access on-line pharmacies. Moreover, self-regulation will achieve only
limited success in preventing prescription fraud against on-line
pharmacies compared to a comprehensive statutory framework.
Therefore, E-SIGN has effectively blocked Washington's ability to
address the problem of prescription fraud against on-line pharmacies and
subsequently prevent the attendant harms to its citizens.
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